iPSC-derived dopaminergic neurons for parkinson’s disease


Parkinson’s disease (PD) is a neurodegenerative disorder resulting from the death of midbrain dopaminergic neurons and currently remains incurable despite enormous research efforts. The development of induced pluripotent stem cell (iPSC) technology offers the unique possibility to study disease mechanisms in any human tissue including patient-derived dopaminergic neurons. Of particular interest are the inherited monogenic forms of PD as they closely resemble the more common “idiopathic” PD and, through the mutated protein, provide a clear research target. This review provides an overview on the findings of iPSC-based genetic PD studies and explores them for unifying theories underlying PD disease mechanisms.

Original languageEnglish
Title of host publicationEncyclopedia of Tissue Engineering and Regenerative Medicine
Number of pages10
PublisherElsevier B.V.
Publication date01.01.2019
ISBN (Print)9780128137000
ISBN (Electronic)9780128136997
Publication statusPublished - 01.01.2019

Research Areas and Centers

  • Research Area: Medical Genetics


Dive into the research topics of 'iPSC-derived dopaminergic neurons for parkinson’s disease'. Together they form a unique fingerprint.

Cite this